Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Not applicable Interventional Accepts healthy volunteers

First-in-Human Safety Study for Fractomer™ Biomatrix

ClinicalTrials.gov ID: NCT07151638

Public ClinicalTrials.gov record NCT07151638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 8:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Early Feasibility Trial for Fractomer™ Biomatrix: Safety Assessment in Healthy Human Participants

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to evaluate the safety of implanting a new medical device (Fractomer™ Biomatrix) in healthy volunteers. The main question it aims to answer is: How do healthy volunteers react to this injectable implant? Participants will receive a subcutaneous injection of Fractomer and their health will be monitored. After the monitoring period, the implant will be removed.

Study identification

NCT ID
NCT07151638
Recruitment status
Suspended
Study type
Interventional
Phase
Not applicable
Lead sponsor
inSoma Bio, Inc.
Industry
Enrollment
2 participants

Conditions and interventions

Eligibility (public fields only)

Age range
22 Years to 55 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2025
Primary completion
Dec 21, 2026
Completion
Jan 21, 2027
Last update posted
Jun 25, 2026

2025 – 2027

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Nucleus Network Saint Paul Minnesota 55114

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Soft Tissue trials

Other public records listing Soft Tissue. Sorted by last update posted; newest first. Not a recommendation.

All Soft Tissue trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07151638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2026 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07151638 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →